Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Commissioner’s National Priority Voucher (CNPV)
Pharma
After 2-month delay, Sanofi gains FDA expansion for Tzield
Sanofi has scored an FDA expansion for its Type 1 diabetes treatment Tzield. The decision came nearly two months after its original target date.
Kevin Dunleavy
Jun 15, 2026 11:25am
Fierce Biotech
At CNPV hearing, industry support meets ‘concern’ from experts
Jun 5, 2026 5:00am
Biopharma rallies behind Pazdur to lead FDA. But is he willing?
May 14, 2026 11:05am
Partner's Bizengri passes muster in FDA national priority pilot
May 11, 2026 11:08am
Sanofi asks out of FDA's CNPV program for Tzield expansion: Stat
May 6, 2026 4:00pm
Regeneron ushers in new era with inaugural gene therapy approval
Apr 23, 2026 3:22pm
